Japanese Encephalitis vaccination campaign expands to seven more districts in Tamil Nadu

Tamil Nadu is expanding its Japanese Encephalitis (JE) vaccination program to seven additional districts, aiming to administer a single dose of the JE vaccine to over 27.63 lakh children aged one to 15. The campaign will be conducted in government and government-aided schools, anganwadi centers, orphanages, and juvenile homes in a phased manner from August to November. JE is a mosquito-borne zoonotic viral disease affecting the central nervous system, causing severe complications, seizures, death, and neurological sequelae, particularly in children due to lack of cumulative immunity. The vaccination program, initially implemented in 15 endemic districts since 2007, is a one-time campaign integrated into the routine immunization schedule.

Key Points

  • Tamil Nadu is expanding its Japanese Encephalitis (JE) vaccination program to seven new districts.
  • The campaign targets 27.63 lakh children aged 1-15 with a single dose of the JE vaccine.
  • JE is a mosquito-borne zoonotic viral disease that causes severe neurological complications and has a high case fatality rate, especially in children.
  • The vaccination drive will be conducted in schools, anganwadi centers, orphanages, and juvenile homes in a phased manner.
  • The JE vaccination program, initiated in 2007 in 15 endemic districts, is a one-time campaign integrated into routine immunization.

Exam Facts

  • JE is a mosquito-borne zoonotic viral disease transmitted by Culex mosquitoes.
  • The campaign aims to vaccinate 27,63,152 children aged one to 15.
  • The program is expanding to seven additional districts in Tamil Nadu, including Chengalpattu, Tirunelveli, Tenkasi, Kancheepuram, Nagapattinam, and Vellore.
  • The JE vaccination program was first implemented in 2007 in 15 endemic revenue districts.

Read it. Retain it. Recall it.

Get spaced-repetition flashcards, daily quizzes and offline access — free on Android.

Get it on Google Play

All current affairs of 14 August 2025